Atomic modelling and systematic mutagenesis identify residues in multiple drug binding sites that are essential for drug resistance in the major Candida transporter Cdr1
- 1 November 2016
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1858 (11) , 2858-2870
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology (DBT No.·BT/01/CEIB/10/III/02, BT/PR7392/MED/29/652/2012, BT/PR14879/BRB10/885/2010)
- Council of Scientific & Industrial Research, India (09/263(0866)/2010-EMR-I)
- The French League against Cancer
- ANR (13-BSV5-0001-01)
- ANR (14-CE09-0024-03)
This publication has 40 references indexed in Scilit:
- FK520 interacts with the discrete intrahelical amino acids of multidrug transporter Cdr1 protein and acts as antagonist to selectively chemosensitize azole-resistant clinical isolates ofCandida albicansFEMS Yeast Research, 2014
- Functionally Relevant Residues of Cdr1p: A Multidrug ABC Transporter of Human Pathogenic Candida albicansJournal of Amino Acids, 2011
- Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicansEuropean Journal of Medicinal Chemistry, 2010
- Membrane Porters of ATP-Binding Cassette Transport Systems Are PolyphyleticThe Journal of Membrane Biology, 2009
- Curcumin Modulates Efflux Mediated by Yeast ABC Multidrug Transporters and Is Synergistic with AntifungalsAntimicrobial Agents and Chemotherapy, 2009
- Evolution of antifungal-drug resistance: mechanisms and pathogen fitnessNature Reviews Microbiology, 2005
- Structure and function of efflux pumps that confer resistance to drugsBiochemical Journal, 2003
- Antifungal agents: mechanisms of actionTrends in Microbiology, 2003
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Importance of antifungal drug-resistance: clinical significance and need for novel therapyExpert Opinion on Investigational Drugs, 1998